---
title: EMA's December Updates Unwrapped! | EXTEDO
description: EMA publishes three updates in december 2024 - find them here!
---

![](https://www.extedo.com/hs-fs/hubfs/Pictures/Blog%20Post%20Banners/Blog%20Post%20Banner%20_%20ISO%20IEC%2027001.png?width=576&height=265&name=Blog%20Post%20Banner%20_%20ISO%20IEC%2027001.png)

![](https://www.extedo.com/hs-fs/hubfs/b0cb190cbd7efaee1435dde1e0fdaa3c.png)

# EMA's December Updates Unwrapped!

Just in time before the holidays in December 2024, the European Medicines Agency (EMA) gave us not just one but three updates. As you might need them to make your subsequent submissions shine, we have unwrapped and briefly summarized them here.

**1. eCTD EU Harmonized Technical Guidance Version 6 is available now**

With this recently published guidance document, the EMA intends to assist pharmaceutical companies with the submission of regulatory information in electronic Common Technical Document format (eCTD) to the National Competent Authorities (NCAs) as well as to the EMA. It is aligned with the EU M1 eCTD Specification v3.1 and the Validation Criteria v8.1. NCAs can use this guidance to harmonize the requirements for eCTD submissions in EU/EEA. The several changes are in accordance with the EU M1 eCTD Specification 3.1.

The timelines for the optional and mandatory use are as follows:

- (**optional** use): From 1 December 2024 eCTDs compliant with EU M1 v3.0.4 **or** v3.1 and Validation Criteria v7.1 or v8.1 are accepted.
- (**mandatory** use): From 1 March 2025, only eCTDs that are compliant with EU M1 v3.1 and Validation Criteria v8.1 will be accepted.

 You can [access the complete document here](https://esubmission.ema.europa.eu/ectd/docs/Harmonised%20guidance%20eCTD%20-%20version%206.0.pdf), together with the [Release notes](https://esubmission.ema.europa.eu/ectd/docs/Release%20notes%20for%20Harmonised%20Technical%20Guidance%20for%20eCTD%20Submissions%20in%20the%20EU%20-%20version%206%20-%20Nov.pdf).

 

**2. EU eCTD v4.0 Controlled Vocabularies in .xml format available**

          
The EMA published a package containing the first version of the [eCTD v4.0 Controlled Vocabularies](https://esubmission.ema.europa.eu/eCTD%20NMV/EU%20eCTD%20v4.0%20Controlled%20Vocabularies%20v1.zip) in            genericode .xml format. They are complementing the MSExcel (.xlsx) version which was published in                [October.  
](https://extedo.atlassian.net/wiki/x/bALZFw)

 

**3. eSubmissions Gateway: Naming of the Working Documents Folder**

 

Regarding the eSubmissions Gateway, we learn more about the Working Documents Folder. It should always be called "xxxx-workingdocuments" and be provided on the same submission zip package   

containing the eCTD. The number (xxxx) needs to match the number of the eCTD sequence being submitted. Any deviation will lead to a failed submission, meaning the package will have to be resubmitted with the correct naming, but the reason for the invalid submission is not clearly described in the message the applicant will receive.

 

Find [more information here.](https://esubmission.ema.europa.eu/index.htm)

![whiteWaveTop](https://www.extedo.com/hs-fs/hubfs/whiteWaveTop.webp?width=576&height=44&name=whiteWaveTop.webp)

## Latest Blog Posts

![500](https://www.extedo.com/hs-fs/hubfs/Illustrations/Blog%20Posts/Blog%20Post%20Thumbnails/Introduction%20of%20ePI.png?width=64&height=64&name=Introduction%20of%20ePI.png) ![500](https://www.extedo.com/hs-fs/hubfs/Illustrations/Blog%20Posts/Blog%20Post%20Thumbnails/Introduction%20of%20ePI.png?width=500&height=500&name=Introduction%20of%20ePI.png)

 Introduction of ePI – The Future of Medicines Information

[Read more **](https://www.extedo.com/blog/introduction-of-epi-the-future-of-medicines-information) 

<https://www.extedo.com/blog/introduction-of-epi-the-future-of-medicines-information>

![500](https://www.extedo.com/hs-fs/hubfs/Illustrations/Blog%20Posts/Blog%20Post%20Thumbnails/EEXTEDO%20as%20Founding%20Member%20of%20Gravitate%20Healths%20Open%20E2E%20ePI%20Community.png?width=64&height=64&name=EEXTEDO%20as%20Founding%20Member%20of%20Gravitate%20Healths%20Open%20E2E%20ePI%20Community.png) ![500](https://www.extedo.com/hs-fs/hubfs/Illustrations/Blog%20Posts/Blog%20Post%20Thumbnails/EEXTEDO%20as%20Founding%20Member%20of%20Gravitate%20Healths%20Open%20E2E%20ePI%20Community.png?width=500&height=500&name=EEXTEDO%20as%20Founding%20Member%20of%20Gravitate%20Healths%20Open%20E2E%20ePI%20Community.png)

 Egyptian Drug Authority and EXTEDO Launch Phase II of Egypt’s Pharmaceutical Digital Transformation

[Read more **](https://www.extedo.com/blog/egyptian-drug-authority-and-extedo-launch-phase-ii-of-egypts-pharmaceutical-digital-transformation) 

<https://www.extedo.com/blog/egyptian-drug-authority-and-extedo-launch-phase-ii-of-egypts-pharmaceutical-digital-transformation>

![500](https://www.extedo.com/hs-fs/hubfs/Pictures/Blog%20Post%20Thumbnails/Upcoming%20Events%20at%20the%20European%20Medicines%20Agency%20(EMA)%20Your%20Essential%20Guide%20for%20Planning%20(thumb).png?width=64&height=64&name=Upcoming%20Events%20at%20the%20European%20Medicines%20Agency%20(EMA)%20Your%20Essential%20Guide%20for%20Planning%20(thumb).png) ![500](https://www.extedo.com/hs-fs/hubfs/Pictures/Blog%20Post%20Thumbnails/Upcoming%20Events%20at%20the%20European%20Medicines%20Agency%20(EMA)%20Your%20Essential%20Guide%20for%20Planning%20(thumb).png?width=500&height=500&name=Upcoming%20Events%20at%20the%20European%20Medicines%20Agency%20(EMA)%20Your%20Essential%20Guide%20for%20Planning%20(thumb).png)

 EMA PMS Info Day 2026: The Future of Data-Driven Medicines Regulation in Europe

[Read more **](https://www.extedo.com/blog/ema-pms-info-day-2026-the-future-of-data-driven-medicines-regulation-in-europe) 

<https://www.extedo.com/blog/ema-pms-info-day-2026-the-future-of-data-driven-medicines-regulation-in-europe>

![500](https://www.extedo.com/hs-fs/hubfs/Illustrations/Blog%20Posts/Blog%20Post%20Thumbnails/US%20FDA_eCTD%20v4.png?width=64&height=64&name=US%20FDA_eCTD%20v4.png) ![500](https://www.extedo.com/hs-fs/hubfs/Illustrations/Blog%20Posts/Blog%20Post%20Thumbnails/US%20FDA_eCTD%20v4.png?width=500&height=500&name=US%20FDA_eCTD%20v4.png)

 US FDA CDER Reveals Why Most eCTD v4 Submissions Fail (And How to Fix Them)

[Read more **](https://www.extedo.com/blog/us-fda-cder-reveals-why-most-ectd-v4-submissions-fail-and-how-to-fix-them) 

<https://www.extedo.com/blog/us-fda-cder-reveals-why-most-ectd-v4-submissions-fail-and-how-to-fix-them>

[See more blog posts](https://www.extedo.com/blog)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "EXTEDO",
    "url" : "https://www.extedo.com/blog/author/extedo"
  },
  "dateModified" : "2025-01-10T09:44:05.600Z",
  "datePublished" : "2025-01-10T09:42:23.000Z",
  "headline" : "EMA's December Updates Unwrapped!",
  "mainEntityOfPage" : {
    "@id" : "https://www.extedo.com/blog/emas-december-updates-unwrapped",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://www.extedo.com/hubfs/logo.png"
    },
    "name" : "EXTEDO GmbH"
  }
}
```